NAMS logo

NAMS Cash From Investing

Annual CFI

-$62.85 M
-$62.82 M-261766.67%

December 31, 2024


Summary


Performance

NAMS Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAMScash flowmetrics:

Quarterly CFI

-$62.18 M
-$62.10 M-82805.33%

December 31, 2024


Summary


Performance

NAMS Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAMScash flowmetrics:

TTM CFI

-$62.85 M
-$62.18 M-9252.38%

December 31, 2024


Summary


Performance

NAMS TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAMScash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NAMS Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10000.0%-10000.0%-9252.4%
3 y3 years-10000.0%--
5 y5 years-10000.0%--

NAMS Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%at low<-9999.0%at low<-9999.0%at low
5 y5-year<-9999.0%at low<-9999.0%at low<-9999.0%at low
alltimeall time<-9999.0%at low<-9999.0%at low<-9999.0%at low

NewAmsterdam Pharma Company NV Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$62.85 M(>+9900.0%)
-$62.18 M(>+9900.0%)
-$62.85 M(+9252.4%)
Sep 2024
-
-$75.00 K(-64.1%)
-$672.00 K(+10.9%)
Jun 2024
-
-$209.00 K(-45.7%)
-$606.00 K(+50.7%)
Mar 2024
-
-$385.00 K(>+9900.0%)
-$402.00 K(+1575.0%)
Dec 2023
-$24.00 K
-$3000.00(-66.7%)
-$24.00 K(+14.3%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$9000.00(+80.0%)
-$21.00 K(+75.0%)
Jun 2023
-
-$5000.00(-28.6%)
-$12.00 K(+71.4%)
Mar 2023
-
-$7000.00
-$7000.00
Dec 2022
-$221.00 K(+820.8%)
-
-
Dec 2021
-$24.00 K(+50.0%)
-
-
Dec 2020
-$16.00 K
-
-

FAQ

  • What is NewAmsterdam Pharma Company NV annual cash flow from investing activities?
  • What is the all time high annual CFI for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV annual CFI year-on-year change?
  • What is NewAmsterdam Pharma Company NV quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV quarterly CFI year-on-year change?
  • What is NewAmsterdam Pharma Company NV TTM cash flow from investing activities?
  • What is the all time high TTM CFI for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV TTM CFI year-on-year change?

What is NewAmsterdam Pharma Company NV annual cash flow from investing activities?

The current annual CFI of NAMS is -$62.85 M

What is the all time high annual CFI for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high annual cash flow from investing activities is -$16.00 K

What is NewAmsterdam Pharma Company NV annual CFI year-on-year change?

Over the past year, NAMS annual cash flow from investing activities has changed by -$62.82 M (-261766.67%)

What is NewAmsterdam Pharma Company NV quarterly cash flow from investing activities?

The current quarterly CFI of NAMS is -$62.18 M

What is the all time high quarterly CFI for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high quarterly cash flow from investing activities is -$3000.00

What is NewAmsterdam Pharma Company NV quarterly CFI year-on-year change?

Over the past year, NAMS quarterly cash flow from investing activities has changed by -$62.10 M (-82805.33%)

What is NewAmsterdam Pharma Company NV TTM cash flow from investing activities?

The current TTM CFI of NAMS is -$62.85 M

What is the all time high TTM CFI for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high TTM cash flow from investing activities is -$7000.00

What is NewAmsterdam Pharma Company NV TTM CFI year-on-year change?

Over the past year, NAMS TTM cash flow from investing activities has changed by -$62.18 M (-9252.38%)